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The insulin-like growth factor 1 receptor (IGF-1R) has been suggested to be involved in hepatocyte
differentiation. Human hepatocyte cancer cells and stem cells are known to express IGF-1R whereas
normal hepatocytes do not. In the present study we optimized a differentiation protocol and veriﬁed the
different stages by established markers. The expression levels of IGF-1R and major downstream signaling
proteins during differentiation from human embryonic stem cells (hESC) to mature hepatocytes were
investigated. We could only demonstrate a minor decrease in IGF-1R expression during endodermal
differentiation compared to hESC, but declined substantially (>50%) after hepatic lineage commitment
during the hepatocyte speciﬁcation and maturation stages. This downregulation was paralleled by an
upregulation of ERK 1/2, AKT and insulin substrate-1. Neither inhibition nor activation of IGF-1R had any
essential effect on endoderm differentiation of human embryonic stem cells. Therefore, our data suggest
that IGF-1R downregulation may have a regulatory impact after initiation of hepatic lineage
commitment.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The insulin-like growth factor 1 receptor (IGF-1R) consists of
two ligand-binding, extracellular a-subunits and two b-subunits.
Ligand binding induces autophosphorylation and activation of the
receptor, followed by recruitment of speciﬁc docking proteins,
including Shc and insulin-receptor substrate-1 (IRS1). This leads to
subsequent activation of downstream signaling pathway that
include phosphatidyl inositol 3-kinase (PI3K)/Akt and mitogen-
activated protein kinase (MAPK)/ERK pathways [1e3]. IGF-1R has
been indicated to play an important role in development and dif-
ferentiation [4]. IGF-1R knockouts are embryonically lethal and
embryos exhibit developmental delays in ossiﬁcation, epidermis,
muscles and central nervous system [5]. In addition, roles for IGF-
1R in inducing differentiation in hematopoietic cells [6] and he-
patocyte differentiation from mesenchymal stem cells [7] haveInc. This is an open access article ubeen reported. During hepatocyte differentiation IGF-1R expression
is downregulated, hESC have been shown to express high levels of
IGF-1R [8], while normal hepatocytes (nHeps) do not express any
detectable levels of IGF-1R mRNA or protein [9,10].
In the present study we investigated the expression pattern of
the IGF-1R and major downstream signaling proteins during dif-
ferentiation of hESCs to mature hepatocytes. To our knowledge this
is the ﬁrst study showing that downregulation of IGF-1R occurs
after hepatic linage commitment during the hepatocyte speciﬁca-
tion and maturation stages of differentiation.2. Materials and methods
2.1. Cell culture and reagents
H1 (WA01) hESC line was obtained from WiCell Research
Institute Inc. (Madison, WI). Undifferentiated hESCs were main-
tained on mouse embryonic ﬁbroblasts (SNL feeder cells) obtained
from (Professor Klas Wiman, Karolinska Institutet, Stockholm,
Sweden) in 5% CO2. Before seeding the hESC, mouse embryonic SNLnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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St.louis, MO) to arrest cells in mitosis, then cultured in Dulbecco's
modiﬁed Eagle's medium (DMEM) supplemented with 10% Fetal
Bovine Serum (FBS), and 1% non-essential amino acids (all from
Invitrogen, Paisley, UK). The hESCs were cultured in DMEM-F12
with 20% Knockout Serum Replacement (KSR) in 1 mM L-gluta-
mine, 10 mM nonessential amino acids (Invitrogen), 50 mM b-
mercaptoethanol (Sigma), and 4 ng/ml FGF-2 (R&D Systems, Min-
neapolis, MN). For differentiation passaged cells were seeded on 5%
Matrigel-Growth Factor Reduced (R&D Systems) and left for 48 h in
maintenance medium. Growth media was then changed to DMEM/
F12 containing 1 mM nonessential amino acids, L-glutamine,
100 ng/ml FGF-2, Activin A and/or BMP-4 (R&D systems) and left
for four days. The concentration of serum (FBS) was 0% for the ﬁrst
day, 0.2% for the second day and 2% for third and fourth day. Cells
were then grown for eight days in DMEM/F12 containing 10%FBS,
1 mM nonessential amino acids, L-glutamine, 1% dimethyl sulfoxide
(DMSO) and 100 ng/ml HGF (R&D systems). Finally cells were
grown for four days in DMEM/F12 containing 10%FBS, 1 mM
nonessential amino acids, L-glutamine, 107 dexamethasone and/or
100 ng/ml oncostain M (Sigma-Alrich).
2.2. Western blotting
Cells were lysed in modiﬁed RIPA buffer (50 mM Tris pH 7.4,
150 mM NaCl, 1% NP-40, 1 mM EDTA, 0.25% sodium deoxycholate)
containing protease (Roche, Mannheim, Germany) and phospha-
tase (Sigma) inhibitors. Protein concentrations were determined
using BCA (Pierce Biotechnology, Rockford, IL). Antibodies used
were goat anti-FoxA2, goat anti-GATA4 or goat anti-Sox17 from
(R&D Systems) rabbit anti-E-cadherin, rabbit anti-brachyury, rabbit
anti-IGF-1RY1135 rabbit anti-IGF-1R, rabbit anti-IRS1, rabbit anti-
AKT, or rabbit anti-Erk1/2from (Cell Signaling Technology, Bev-
erly, MA) mouse anti-Oct 3/4, rabbit anti-GAPDH or goat anti-
HNF4a from (Santa Cruz Biotechnology, Santa Cruz, CA) rabbit anti-
Sox7 or rabbit anti-AFP from (Sigma Aldrich) or rabbit-anti Nanog
from (Abcam, Cambridge, UK). Secondary anti-rabbit/mouse/goat
IgG horseradish peroxidase-conjugated antibodies were from
(Amersham) followed by signal detection using enhanced lumi-
nescence Hyperﬁlm-ECL (Amersham).
2.3. Flowcytometry
Cells were ﬁxed with 70% ethanol, incubated with anti-ASGPR1
antibody (Abcam) for 1 h at room temperature (RT), washed with
PBS (Hyclone, Logan, UT) containing 1% bovine serum albumin
(BSA) and incubated with goat anti-rabbit Alexa Fluor 488-conju-
gated antibody (Invitrogen). Following analysis with ﬂow cytom-
etry, the data were processed with the Cell Quest software (Becton
Dickinson, San Jose, CA).
2.4. ELISA albumin assay
Culture medium was replaced 3 days prior to the assay with
1.5 ml blank DMEM medium. Conditioned medium was harvested
and assayed for albumin secretion using Human Albumin ELISA
Quantitation kit (Bethyl Laboratory, Inc., Montgomery, TX)
following the manufacturer's instructions. Albumin secretion levels
were normalized with total protein of differentiated hepatocyte
like cells at concentration of 0.125 mg/ml protein.
2.5. Urea assay
Culture medium was replaced 3 days prior to the assay with
1.5 ml blank DMEM/F12 medium. Conditioned medium washarvested and assayed for albumin secretion using urea enzymatic
assay kit (Bioo Scientiﬁc, Austin, TX) following the manufacturer's
instructions. Urea secretion levels were normalized with total
protein of differentiated hepatocyte like cells at concentration of
0.27 mg/ml protein.
2.6. Periodic acid schiff (PAS) staining
The PAS staining systemwas purchased from Sigma-Aldrich. The
differentiated cells were ﬁxed in 4% paraformaldehyde for 20 min
and then intracellular glycogen was stained using PAS staining
according to the manufacturer's instructions.
3. Results
Optimization of a protocol for efﬁcient differentiation of
hepatocyte-like cells from human embryonic stem cells.
We optimized a three-step protocol for human hepatocyte dif-
ferentiation based on the understanding of the mechanisms un-
derlying mouse embryogenesis and modiﬁcations of previous
reported protocols [11,12]. Fig. 1A illustrates the three differentia-
tion steps (endoderm, hepatocyte speciﬁcation and hepatocyte
maturation) and the procedures we used to reach each of them.
Human embryonic stem cells (hESCs) were maintained on mitoti-
cally inactive mouse embryonic ﬁbroblast (MEF) feeder layer in
embryonic stem cell (ES) culture media. Under these conditions
hESCs expressed pluripotency markers, including Oct3/4 and
Nanog (Fig. 1B). To initiate differentiation, hESCs were cultured on
Matrigel-Growth Factor Reduced® (see Material and methods) for
two days, followed by culturing in DMEM/F12 media containing
FGF-2, gradual concentration of serum and various concentrations
of Activin A and (bone morphogenetic protein 4) BMP4 (0, 20, 40,
60 and 80 ng/ml) (Fig. 1B). After 4 days of culture, the simultaneous
addition of BMP4 resulted in higher expression of deﬁnitive
endoderm markers as compared with Activin A treatment alone;
GATA binding protein 4 (GATA4), sex determining region Y box 17
(SOX17), foreheads box A2 (FOXA2), while expressing lower levels
of Oct3/4 and Nanog (Fig. 1B). Surprisingly, BMP4 concentrations
higher than 40 ng/ml induced differentiation of extra-embryonic
endoderm as indicated by the increased expression of SOX7
(Fig. 1B). Based on these data, we chose to use 60 ng/ml Activin A
and 40 ng/ml BMP4 in the subsequent differentiation experiments.
Culturing cells in RPMI supplied with B27 as described in other
studies [11] resulted in lower degree of endoderm differentiation,
and RPMI alone in lower survival rate (data not shown).
Cultures of induced deﬁnitive endodermal cells were next
moved to DMEM/F12 supplemented with 10% serum,1% DMSO and
100 ng/ml hepatocyte growth factor (HGF) and maintained for 7
days. As shown in Fig. 1C, cell cultures supplemented with 10%
serum and DMSO/HGF resulted in diminished Oct3/4, Nanog, SOX7
and FoxA2 expression but initiated expression of AFP and hepato-
cyte nuclear factor 4a (HNF4a). For induction of the ﬁnal stage of
differentiation (mature hepatocytes) we cultured the speciﬁed
hepatocytes in DMEM/F12 supplemented with 10% serum and
either dexamethasone or oncostatin M (OSM) or a combination of
both. In contrast to the earlier stages, expression of albumin
appeared in the mature hepatocytes (Fig. 1C). After 5 days of cul-
ture, cells treated with the combination of both DEX and OSMwere
found to express the highest levels of the hepatocyte marker al-
bumin as assayed by western blotting (Fig. 2A). Based on ﬂow
cytometry analyses the mature hepatocytes exhibited similar
expression of the hepatocyte marker Asialoglycoprotein receptor 1
(ASGPR1) when treated with DEX alone or DEX þ OSM (66 and
68.6%, respectively), while it was somewhat lower with OSM alone
(45.6%) (Fig. 2B). Culturing of the hepatocyte-like cells for an
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Fig. 1. Generation of hepatocyte-like cells from hESC. (A) Schematic presentation of the used differentiation protocol. See text. (B) WA01 cells (a hESC cell line) grown under
feeder free conditions on reduced-growth factor Matrigel treated with FGF-2 (100 ng/ml) and indicated concentrations of BMP4 and Activin A for 4 days. Cells were then harvested,
lysed for western blot analysis and blotted against stemness protein markers (Oct3/4, Nanog) (green), deﬁnitive endoderm markers (FOXA2, Sox17 and GATA4) (red) and extra-
embryonic endoderm markers (Sox7) (blue). GAPDH was used as loading control. (C) Expression proﬁles of protein markers and transcription factors in the different stages of
hepatocyte differentiation assayed by western blot analysis; stemness protein markers (green), deﬁnitive endoderm markers (red) and hepatic markers (HNF4a, AFP and Albumin)
(brown). nHep was used as positive control. Data are representative of three or more independent experiments. FGF-2: Fibroblast growth factor-2; BMP4: Bone morphogenetic
protein 4; Dex: Dexamethasone; OSM: Oncostatin M; hESC: human embryonic stem cells, nHep: Adult normal hepatocyte. (For interpretation of the references to colour in this
ﬁgure legend, the reader is referred to the web version of this article.)
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signiﬁcantly increased the percentage of ASGPR1 positive cells to
86.5% and also increased the level of albumin expression (data not
shown).
At the completion of the differentiation protocol, the
hepatocyte-like cells were shown to display several known hepatic
functions. Periodic acid-Schiff (PAS) staining indicated glycogen
synthesis by the differentiated cells, in addition to urea and albu-
min secretion (Fig. 2CeE). Moreover, the morphology of the
differentiated cells also shared many characteristics with primary
hepatocytes, including a large cytoplasmic-to-nuclear ratio,
prominent nucleoli and several cells were found to be binucleated
(Fig. 2C). Regarding glycogen synthesis and urea production no
signiﬁcant difference was found between OSM, Dex or Dex/OSM
treated cells. However, the combination of Dex/OSM treatment
resulted in highest albumin secretion, i.e. two-fold of that by OSM
alone, and four-fold of that by Dex alone (Fig. 2D). Again, culturing
of cells for an additional week in complete HBMmedia signiﬁcantly
increased the albumin and Urea secretion (data not shown). Basedon these data, we chose to use the combination of Dex/OSM in the
following experiments.
3.1. Downregulation of IGF-1R expression during hepatocyte
differentiation stages
After establishing the differentiation protocol, we studied the
expression of IGF-1R during hepatocyte differentiation of hESC by
western blotting. During endoderm differentiation IGF-1R expres-
sion was slightly reduced by (8%). However, a dramatic and statis-
tical signiﬁcant reduction (more than 50%) was shown during both
the hepatocyte speciﬁcation and maturation stages (Fig. 3A and B).
As expected, the nHep cells expressed hardly any IGF-1R. Next we
investigated the expression of IGF-1R downstream signaling pro-
teins; i.e. insulin receptor substrate-1 (IRS1), ERK (MAPK pathway)
and AKT (PI3K/AKT pathway). As shown, AKT was clearly increased
in all 3 differentiation stages compared to hESC (Fig. 3C). IRS1 was
slightly increased in the hepatocyte speciﬁcation and maturation
steps, while ERK1/2 appeared only in these two stages and was
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Fig. 2. Characteristics of generated hepatocyte-like cells. (A) Western blot analysis showing expression of hepatocyte marker albumin in mature hepatocytes generated by DEX
and/or OSM. hESC was used as negative control. (B) Flowcytometric analysis showing percentage of mature hepatocytes, generated by DEX and/or OSM, positive for hepatocyte
surface marker ASGPR1. The negative control was obtained by omitting the primary antibody. (C) Periodic and Schiff staining of mature hepatocytes generated by DEX and OSM.
Magniﬁcation 4 and 10. Black arrow indicates binucleated cells. (D) Secreted albumin levels in the culture media of mature hepatocytes generated by DEX and/or OSM. The
concentration of albumin in (ng/ml) was assessed by ELISA. Albumin secretion levels were normalized with total protein of differentiated hepatocyte-like cells at a concentration of
0.125 mg/ml protein. Data are presented as means ± SDs of three independent experiments and considered signiﬁcant (*) at P < 0.01 using one way ANOVA. (E) Secreted urea levels
in the culture media (ppm) of mature hepatocytes, generated by DEX and/or OSM, were assessed by urea assay kit. Secretion levels were normalized with total protein of
differentiated hepatocyte-like cells at a concentration of 0.27 mg/ml protein. Data are presented as means ± SDs of three independent experiments. ELISA: enzyme linked
immunosorbent assay, ppm: parts per million.
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proteins were expressed in a manner opposite to the IGF-1R. All of
them, although at a much lower level, were also expressed in nHep
(Fig. 3C).
3.2. Minor role of IGF-1R in endodermal differentiation
To investigate the potential role of IGF-1R in endodermal dif-
ferentiation, NVP-AEW 54, a selective inhibitor of IGF-1R phos-
phorylation, was used to block the IGF-1R activity and IGF-1 ligand
was used to increase activity of IGF-1R during the endoderm dif-
ferentiation. Neither inhibition nor activation of IGF-1R showed any
clear effect on endoderm differentiation as indicated by unchanged
expression levels of the endoderm markers GATA4 and SOX17
(Fig. 4). However, IGF-1R inhibition resulted in a slight reduction in
Nanog and Oct3/4 expression as compared to the control (Fig. 4),
and IGF-1 stimulation showed a slight increase in extra-embryonic
endoderm (SOX7) and mesoderm (as assayed by brachyuryexpression) induction, with no effect on ectoderm induction (E-
cadherin) (Fig. 4).
4. Discussion
Normal hepatocytes (nHeps) do not express any detectable
levels of IGF-1R mRNA or protein [9,10], whereas hESC have been
shown to express high levels of IGF-1R [8]. This suggests a possible
role for IGF-1R in hepatocyte differentiation. In the current study
we aimed to investigate the expression pattern of IGF-1R and the
downstream signaling pathway during hepatocyte differentiation
process. To do so, we modiﬁed a step-wise differentiation protocol
from hESC based on previous studies [11,12]. Direct differentiation
of hepatocytes from hESC has been previously reported as well
[13e15]. However, more and more studies have suggested that the
step-wise differentiation protocol, in a pattern similar to the
embryological development, would be more efﬁcient for hepato-
cyte differentiation [11,12].
IGF-1R
Sp
ec
ifi
ed
 
he
pa
to
cy
te
hE
SC
D
ef
in
iti
ve
 
En
do
de
rm
M
at
ur
e
he
pa
to
cy
te
nH
ep
GAPDH
hE
SC
D
ef
in
iti
ve
 
En
do
de
rm
Sp
ec
ifi
ed
 
he
pa
to
cy
te
M
at
ur
e
he
pa
to
cy
te
nH
ep
0
0.2
0.4
0.6
0.8
1
Fo
ld
 d
iff
er
en
ce
 o
f I
G
F-
1R
 
ex
pr
es
si
on
A
B
C
IRS1
Sp
ec
ifi
ed
 
he
pa
to
cy
te
hE
SC
D
ef
in
iti
ve
 
En
do
de
rm
M
at
ur
e
he
pa
to
cy
te
nH
ep
GAPDH
AKT
ERK1/2
N.S
**
**
Fig. 3. Downregulation of IGF-1R expression during hepatocyte differentiation. (AeC) Cells in the different stages of hepatocyte differentiation (obtained as described in Fig. 1
and the text) were compared for IGF-1R, IRS1, AKT and ERK 1/2 expression using western blot. nHep was used as negative control. GAPDH was loading control. (B) Densitometric
analysis of the Western blots in (A) normalized to GAPDH expression. Data are presented as fold-difference compared to nHep. Data are presented as means ± SDs of three in-
dependent experiments and considered signiﬁcant (**) at P < 0.05 using two-sided t-test. N.S: non-signiﬁcant. IGF-1R: insulin like growth factor 1 receptor.
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nodal signaling [16,17], and treatment of hESCs with Activin A have
been shown to initiate expression of endodermal transcriptional
regulators and markers similar to embryological development
[11,12,18]. As combination of BMP4 and Activin A has been reported
to be more efﬁcient to promote deﬁnitive endodermal formation
[11,19], we investigated various concentrations of Activin A and
BMP4. We found that Activin A and BMP4 at doses of 60 ng/ml and
40 ng/ml, respectively, were optimal for deﬁnitive endoderm dif-
ferentiation. Higher BMP4 concentrations induced formation of
extraembryonic endoderm.
Stepwise additions of FGF, HGF, dexamethasone and/or OSM
drive initiation of similar transcriptional events as in liver organ-
ogenesis [11,12] mimicking the secretion of signaling molecules
from the underlying mesoderm [20]. We found that addition of
FGF-2 and HGF following BMP4 and FGF-2 during endoderm in-
ductionmediated the continuation of FOXA2 and GATA4 expression
at lower levels. The expression of GATA4 and FOXA2 has been
shown to be important for early hepatic gene expression [21,22]
and act as mediators for competence in foregut endoderm [23].
The addition of FGF-2 and HGF also initiated expression of HNF4a
which acts as an essential regulator for hepatocyte differentiation
[24]. For hepatocyte maturation, we found that the combination of
both OSM and dexamethasone was the most efﬁcient in inducing
hepatic functions, at least regarding albumin production and
secretion. At the end of the differentiation protocol 70% of gener-
ated hepatocyte-like cells were expressing the hepatocyte marker
(ASGPR1), higher than the reported percentage of cells fromprevious studies [11,12]. In addition, they were able to secrete urea
and albumin and to synthesis and store glycogen indicating the
functional ability of the cells. The lower level of albumin secretion
from the generated hepatocyte-like cells in our study compared to
the previous ones [11,12] could be explained by the lower number
of cells used for albumin detection, whichwas equivalent to 125 mg/
ml protein. The fact that, nHep cells were expressing higher levels
of albumin than the differentiated hepctocyte-like cells, was also
reported previously as limitation in the differentiation protocol
[11,12]. However, we also found the nHep in our study to express
detectable levels of AFP, which might indicate fetal origin of the
donor nHep [25].
After optimizing the hepatocyte differentiation protocol, we
investigated the expression pattern of IGF-1R and the downstream
signaling proteins. With the exception of the slight elevated
expression level of AKT, we did not detect any signiﬁcant changes in
expression levels of IGF-1R, ERK 1/2 or IRS1 during endoderm
differentiation. However, after the hepatic linage commitment
starting from hepatocyte speciﬁcation stage a signiﬁcant reduction
in IGF-1R expression occurred. This was paralleled with continued
high level of AKT and increased expression of IRS1 and ERK1/2.
Together, this suggests that the shift to IGF-1R downregulation and
simultaneous upregulation of downstream signaling, starting off
upon hepatic linage commitment, may have a regulatory role in
hepatocyte differentiation.
The importance of ERK/MAPK pathway and the PI3K/AKT
pathway in hepatocyte differentiation have been pointed out in a
number of previous studies. Magner et al., 2013 showed that
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described in the differentiation protocol (cf. Fig. 1A), followed by western blot analysis
for the indicated markers. Activation and inhibition of IGF-1R was indicated by levels
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inhibited hepatocyte differentiation [26], and Calmont et al., 2006
showed FGF mediated induction of hepatic genes function through
the MAPK pathway [27]. In addition other studies have demon-
strated the importance of both PI3K/AKT and ERK/MAPK pathway
in hepatocyte regeneration after partial hepatectomy [28e30].
These latter studies provide further explanation for the lower
expression of AKT and ERK 1/2 in adult normal hepatocytes as
normal hepatocytes were reported to restore lower levels of AKT
and ERK after liver regeneration [28e30]. Similarly IRS1 was also
reported to restore lower levels after liver regeneration [31].
Further conﬁrmation for the possible regulatory role of IGF-1R
after hepatic linage commitment came from the observation that
neither inhibition nor activation of IGF-1R had any signiﬁcant effect
on endoderm differentiation markers. Although it is important to
point out that inhibition of IGF-1R promoted more efﬁcient dif-
ferentiation and IGF-1R stimulation enhanced the mesoderm,
extraembryonic endoderm differentiation. It's also important to
note that our results are not in line with some of the ﬁndings from
the previous study by Magner et al., 2013, which showed that IGF-
1R expression levels remain the same during hepatocyte differen-
tiation. As the previous mentioned study was the only one to report
detectable levels of IGF-1R in differentiated hepctocyte [9,10], this
suggests more investigations about the role of IGF-1R in hepctocyte
differentiation are needed.In conclusion, our data suggests that changes in expression of
IGF-1R and downstream signaling proteins occurring after initia-
tion of hepatic linage commitment may play a regulatory role for
hepatocyte differentiation from embryonic stem cells.
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